Literature DB >> 30300005

Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.

Kerem Ozturk1, Mehmet Gencturk2, Emiro Caicedo-Granados3, Faqian Li4, Zuzan Cayci2.   

Abstract

OBJECTIVE: We aimed to evaluate the contribution of different standardized uptake value (SUV) parameters generated from pretreatment 18F-FDG PET/CT in the characterization of sinonasal neoplasms with histopathologic correlations.
MATERIALS AND METHODS: This retrospective study included 97 consecutive patients (58 men, 39 women; age range, 20-93 years; mean age, 62 years) with pathologically proven untreated sinonasal neoplasms who underwent FDG PET/CT from February 2010 to August 2017. Semiquantitative analysis of primary tumors were performed to evaluate the maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), and the ratio of the SUVmax of the primary tumor to the SUVmean of mediastinal blood pool, which we refer to here as " SUVratio." Various sinonasal tumor histopathologic subgroups (n = 14) were analyzed. The Kruskal-Wallis test was used to compare the SUVmax, SUVmean, and SUVratio with the histopathologic diagnosis.
RESULTS: Mean values of SUVmax, SUVmean, and SUVratio for the sinonasal neoplasms were 16.6 ± 9.7 (SD), 8.6 ± 5.1, and 5.9 ± 3.7, respectively, and each parameter was significantly different between histopathologic types (p < 0.05). Mean values of SUVmax, SUVmean, and SUVratio were higher in sinonasal undifferentiated carcinoma (SNUC) than in olfactory neuroblastoma, metastasis, and adenoid cystic carcinoma (p < 0.05). Mean values of SUVmax and SUVmean were higher in squamous cell carcinoma (SCC) than in olfactory neuroblastoma and metastasis (p < 0.05). Also, mean SUVmax was higher in SCC and SNUC than in poorly differentiated carcinoma (p < 0.05). Mean SUVratio was higher in SCC than in small cell carcinoma, olfactory neuroblastoma, and adenoid cystic carcinoma (p < 0.05).
CONCLUSION: We conclude that different SUV parameters from FDG PET/CT can be used as so-called "metabolic biopsy" to categorize sinonasal neoplasms into different histopathologic subgroups because it can help in the characterization of some of the more common subgroups of sinonasal neoplasms. However, we found that there is overlap in FDG uptake values among some of the rare histologic subgroups; hence, surgical biopsy is still needed for differentiation of histologic subtypes of aggressive sinonasal masses.

Entities:  

Keywords:  FDG PET/CT; maximum standardized uptake value (SUVmax); mean standardized uptake value (SUVmean); sinonasal neoplasms; standardized uptake value ratio (SUVratio)

Mesh:

Substances:

Year:  2018        PMID: 30300005     DOI: 10.2214/AJR.18.19501

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors.

Authors:  Kerem Ozturk; Mehmet Gencturk; Emiro Caicedo-Granados; Faqian Li; Zuzan Cayci
Journal:  Neuroradiol J       Date:  2019-08-28

Review 2.  PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology.

Authors:  Richard H Wiggins; John M Hoffman; Gabriel C Fine; Matthew F Covington; Ahmed Ebada Salem; Bhasker R Koppula; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits.

Authors:  Yuming Jiang; Qingyu Yuan; Wenbing Lv; Sujuan Xi; Weicai Huang; Zepang Sun; Hao Chen; Liying Zhao; Wei Liu; Yanfeng Hu; Lijun Lu; Jianhua Ma; Tuanjie Li; Jiang Yu; Quanshi Wang; Guoxin Li
Journal:  Theranostics       Date:  2018-11-12       Impact factor: 11.556

4.  [68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas.

Authors:  Nika Guberina; Lukas Kessler; Christoph Pöttgen; Maja Guberina; Martin Metzenmacher; Ken Herrmann; Maja Mucha; Christoph Rischpler; Frank Indenkämpen; Jens T Siveke; Jürgen Treckmann; Lale Umutlu; Stefan Kasper; Wolfgang P Fendler; Martin Stuschke
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.